Emcure Pharmaceuticals Limited — Melphalan Exporter Profile
Indian Pharmaceutical Exporter · #1 for Melphalan · $9.3M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #1 Indian exporter of Melphalan with $9.3M in export value and 221 verified shipments. Emcure Pharmaceuticals Limited holds a 69.3% market share in Melphalan exports across 18 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Melphalan Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Melphalan?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.6M | 79 | 36.0% |
| MALTA | $935.1K | 51 | 20.9% |
| SAUDI ARABIA | $351.2K | 14 | 7.8% |
| RUSSIA | $300.0K | 6 | 6.7% |
| CANADA | $286.1K | 6 | 6.4% |
| ALGERIA | $187.3K | 26 | 4.2% |
| THAILAND | $131.5K | 3 | 2.9% |
| ITALY | $124.7K | 6 | 2.8% |
| KOREA,REPUBLIC OF | $100.0K | 2 | 2.2% |
| KAZAKISTAN | $93.4K | 3 | 2.1% |
Emcure Pharmaceuticals Limited exports Melphalan to 25 countries. The largest destination is UNITED KINGDOM accounting for 36.0% of Emcure Pharmaceuticals Limited's Melphalan shipments, followed by MALTA (20.9%) and SAUDI ARABIA (7.8%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Melphalan from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TILLOMED LABORATORIES LTD | UNITED KINGDOM | $957.7K | 46 |
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $578.4K | 28 |
| TILLOMED MALTA LTD | MALTA | $549.9K | 32 |
| TILLOMED MALTA LIMITED | MALTA | $384.9K | 18 |
| FARMAMONDO LLC | RUSSIA | $250.0K | 5 |
| ARABIAN HEALTH CARE SUPPLY CO. | SAUDI ARABIA | $232.7K | 8 |
| MARCAN PHARMACEUTICALS INC | CANADA | $150.0K | 3 |
| ACE PHARMA CO. LTD. | KOREA,REPUBLIC OF | $150.0K | 4 |
| ALLIANCE PHARMA CO., LTD. | THAILAND | $100.0K | 2 |
| PHARMACIE CENTRALE DES HOPITAUX | ALGERIA | $97.8K | 4 |
Emcure Pharmaceuticals Limited supplies Melphalan to 36 buyers globally. The largest buyer is TILLOMED LABORATORIES LTD (UNITED KINGDOM), followed by TILLOMED LABORATORIES LIMITED (UNITED KINGDOM) and TILLOMED MALTA LTD (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Melphalan Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $11.1M worth of Melphalan through 838 shipments from 153 suppliers to 97 countries, serving 272 buyers globally. Emcure Pharmaceuticals Limited contributes $9.3M to this total, accounting for 69.3% of India's Melphalan exports. Emcure Pharmaceuticals Limited ships Melphalan to 25 countries through 36 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Melphalan Exports?
Emcure Pharmaceuticals Limited's average Melphalan shipment value is $42.0K per consignment, based on 221 shipments totaling $9.3M. The largest destination is UNITED KINGDOM (36.0% of Emcure Pharmaceuticals Limited's Melphalan exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Melphalan Exporters?
Emcure Pharmaceuticals Limited ranks #1 among 153 Indian Melphalan exporters with a 69.3% market share. The top 3 exporters are EMCURE PHARMACEUTICALS LIMITED ($8.8M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($1.0M), EMCURE PHARMACEUTICALS LTD ($443.8K). Emcure Pharmaceuticals Limited processed 221 shipments to 18 destination countries.
What Melphalan Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA: MEGVAL INJECTION (MELPHALAN HYDR | $336.0K | 8 |
| MEDICINES Combi Pack of Melphalan Hydrochloride for Injection 50 mg/vial (Lyophilized) & Sterile Diluent for | $208.4K | 12 |
| MEDICINES Melphalan 50mg powder and Solv | $205.9K | 12 |
| MEDICINES Combi Pack of Melphalan Hydrochloride for Injection 50 mg vial Lyophilized Sterile Diluent for | $204.3K | 10 |
| COMBI PACK OF MELPHALAN HYDROCHLORIDE FOR INJECTION 50 MG/VIAL (LYOPHILIZED) & STERILE DILUENT FOR MELPHALAN BATCH NO: C | $200.0K | 4 |
| PHARMA: MEGVAL 50MG INJECTION (MELPHALAN | $133.6K | 3 |
| MEDICINES MELPHALAN Inj 50mg 2.5mL FIL I | $120.8K | 6 |
| MEDICINES MELPHALAN 50mg POW & SOL INJ.Z | $106.5K | 4 |
| MEDICINES MELPHALAN 50mg 2.5mL FIL INJ | $100.0K | 2 |
| MEDICINES MELPHALAN 50 MG WT 2.5 mL FILINJ WITHSLEEVE-FR BATCH NO CP230007 , MANUFACTURING Aug 2023, EXP Jul 2025 | $100.0K | 2 |
Emcure Pharmaceuticals Limited exports 112 distinct Melphalan formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA: MEGVAL INJECTION (MELPHALAN HYDR with 8 shipments worth $336.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Melphalan to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Melphalan to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Melphalan Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED ★ | $8.8M | 221 | 18 | $40.0K |
| 2 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $1.0M | 22 | 2 | $46.5K |
| 4 | EMCURE PHARMACEUTICALS LTD | $443.8K | 15 | 6 | $29.6K |
Emcure Pharmaceuticals Limited ranks #1 among 153 Indian Melphalan exporters. Average shipment value of $40.0K compared to the market average of $72.8K. The closest competitors by value are SUN PHARMACEUTICAL INDUSTRIES LIMITED and EMCURE PHARMACEUTICALS LTD.
Which Indian Ports Ship Melphalan Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 238 | 28.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 199 | 23.7% |
| Bombay Air | 52 | 6.2% |
| DELHI AIR | 49 | 5.8% |
| DELHI AIR CARGO ACC (INDEL4) | 36 | 4.3% |
| HYDERABAD ACC (INHYD4) | 35 | 4.2% |
| HYDERABAD AIR | 34 | 4.1% |
| Bombay Air Cargo | 25 | 3.0% |
What Other Advanced Oncology Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Melphalan Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Melphalan, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Atazanavir. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Melphalan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Melphalan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 236 individual customs records matching Emcure Pharmaceuticals Limited exporting Melphalan, covering 112 formulations to 25 countries via 36 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 272+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Melphalan Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Melphalan exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Melphalan Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Melphalan. For current shipment-level data, contact TransData Nexus.